A detailed history of Capital City Trust CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Capital City Trust CO holds 36,309 shares of ABBV stock, worth $6.03 Million. This represents 1.85% of its overall portfolio holdings.

Number of Shares
36,309
Previous 37,432 3.0%
Holding current value
$6.03 Million
Previous $5.8 Million 13.98%
% of portfolio
1.85%
Previous 1.73%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$159.82 - $182.1 $179,477 - $204,498
-1,123 Reduced 3.0%
36,309 $6.61 Million
Q4 2023

Jan 19, 2024

BUY
$137.6 - $154.97 $80,496 - $90,657
585 Added 1.59%
37,432 $5.8 Million
Q3 2023

Oct 12, 2023

SELL
$133.59 - $154.65 $489,206 - $566,328
-3,662 Reduced 9.04%
36,847 $5.49 Million
Q2 2023

Jul 27, 2023

SELL
$132.51 - $164.9 $198,632 - $247,185
-1,499 Reduced 3.57%
40,509 $5.46 Million
Q1 2023

Apr 19, 2023

BUY
$144.61 - $166.54 $48,444 - $55,790
335 Added 0.8%
42,008 $6.69 Million
Q4 2022

Jan 27, 2023

SELL
$138.31 - $165.87 $61,547 - $73,812
-445 Reduced 1.06%
41,673 $0
Q3 2022

Oct 21, 2022

BUY
$134.21 - $153.93 $32,344 - $37,097
241 Added 0.58%
42,118 $5.65 Million
Q2 2022

Jul 15, 2022

SELL
$137.62 - $174.96 $24,083 - $30,618
-175 Reduced 0.42%
41,877 $6.41 Million
Q1 2022

Apr 20, 2022

SELL
$131.98 - $163.75 $31,015 - $38,481
-235 Reduced 0.56%
42,052 $6.82 Million
Q4 2021

Jan 26, 2022

BUY
$107.43 - $135.93 $15,469 - $19,573
144 Added 0.34%
42,287 $5.73 Million
Q3 2021

Oct 19, 2021

BUY
$106.4 - $120.78 $54,476 - $61,839
512 Added 1.23%
42,143 $4.55 Million
Q2 2021

Jul 23, 2021

BUY
$105.21 - $117.21 $68,702 - $76,538
653 Added 1.59%
41,631 $4.69 Million
Q1 2021

May 05, 2021

BUY
$102.3 - $112.62 $116,826 - $128,612
1,142 Added 2.87%
40,978 $4.43 Million
Q4 2020

Jan 14, 2021

BUY
$80.49 - $108.67 $57,308 - $77,373
712 Added 1.82%
39,836 $4.27 Million
Q3 2020

Oct 21, 2020

BUY
$85.91 - $100.83 $143,641 - $168,587
1,672 Added 4.46%
39,124 $3.43 Million
Q2 2020

Jul 15, 2020

BUY
$73.37 - $98.18 $343,591 - $459,776
4,683 Added 14.29%
37,452 $3.68 Million
Q1 2020

Apr 23, 2020

BUY
$64.5 - $97.79 $42,054 - $63,759
652 Added 2.03%
32,769 $2.5 Million
Q4 2019

Jan 15, 2020

BUY
$72.13 - $90.25 $45,946 - $57,489
637 Added 2.02%
32,117 $2.84 Million
Q3 2019

Oct 22, 2019

BUY
$62.98 - $75.72 $46,983 - $56,487
746 Added 2.43%
31,480 $2.38 Million
Q2 2019

Aug 02, 2019

BUY
$65.7 - $83.98 $22,140 - $28,301
337 Added 1.11%
30,734 $2.24 Million
Q1 2019

Apr 19, 2019

BUY
$77.14 - $90.79 $4,242 - $4,993
55 Added 0.18%
30,397 $2.45 Million
Q4 2018

Jan 15, 2019

BUY
$77.85 - $96.01 $28,337 - $34,947
364 Added 1.21%
30,342 $2.8 Million
Q3 2018

Oct 18, 2018

BUY
$88.91 - $98.84 $51,745 - $57,524
582 Added 1.98%
29,978 $2.84 Million
Q2 2018

Jul 20, 2018

BUY
$89.78 - $106.23 $18,853 - $22,308
210 Added 0.72%
29,396 $2.72 Million
Q1 2018

Apr 13, 2018

SELL
$92.01 - $123.21 $107,375 - $143,786
-1,167 Reduced 3.84%
29,186 $2.76 Million
Q4 2017

Jan 12, 2018

BUY
$89.56 - $98.21 $13,881 - $15,222
155 Added 0.51%
30,353 $2.94 Million
Q4 2017

Jan 10, 2018

BUY
$89.56 - $98.21 $176,254 - $193,277
1,968 Added 6.97%
30,198 $2.68 Million
Q3 2017

Oct 11, 2017

BUY
$69.85 - $89.22 $1.97 Million - $2.52 Million
28,230
28,230 $2.05 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $293B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Capital City Trust CO Portfolio

Follow Capital City Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital City Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Capital City Trust CO with notifications on news.